Top NYC, NY Manufacturing Companies With Best Stability & Growth (66)
Mondelēz International, Inc. (NASDAQ: MDLZ) is an American multinational confectionery, food, and beverage company based in Illinois which employs approximately 90,000 individuals around the world. Our Purpose Our purpose is to empower people to snack right. We will lead the future of snacking around the world by offering the right snack, for the right moment, made the right way. Our...
Mondelēz International's Top Stability, Growth & Resilience Strengths
Strong Market Position & Advantage: The company holds leading positions in its core categories, with global leadership in biscuits and a top-tier position in chocolate. This scale and brand equity underpin durable competitive advantage across regions.
Strong Revenue Growth: Recent results show consistent net revenue increases, including a new high and steady organic growth. Momentum has been supported by category focus and execution across key geographies.
Healthy Cash Flow: The business consistently generates strong free cash flow that funds reinvestment and shareholder returns. This cash generation supports resilience through commodity and macro volatility.
Here at Spot & Tango, we are on a mission to make your pet healthier and happier, simplifying your role as a pet parent along the way. Put simply: we exist to create more happy days with your dog. Since 2018, we’ve been cooking up fresh, whole ingredient meals personalized for dogs at prices humans can afford. We even created an...
Spot & Tango's Top Stability, Growth & Resilience Strengths
Market Expansion: Recent moves include a launch in Canada and continued nationwide U.S. shipping, indicating geographic scaling beyond the core market. Capacity build-out at an in-house Pennsylvania facility and cross-border logistics support broader reach.
Product Line Growth: The portfolio has broadened from cooked fresh meals to a distinctive fresh‑dry format and expanded into dental chews and supplements. This wider assortment aims to capture more lifetime value per customer and appeal to varied consumer preferences.
Strong Revenue Growth: Multiple industry and company reports describe material revenue scale with continued year‑over‑year expansion. Leadership hires and manufacturing investments are framed as enabling the next growth chapter.
Dandy is transforming the massive ($400B) but antiquated dental industry. Backed by some of the world's leading venture capital investors, we’re building custom, end-to-end, precision software and manufacturing from the ground up to provide high-quality, consistent, and affordable restorations to our doctors and their patients. 2 million people already have a Dandy product in their mouth and that number is...
.jpg)
Dandy's Top Stability, Growth & Resilience Strengths
Innovation-Driven Growth: Independent coverage highlights AI, robotics, 3D printing, and real-time dentist–lab collaboration across Dandy’s Utah and Texas facilities and software stack. This end-to-end digital model is described as uncommon in the broader lab landscape and positions the company as a tech-forward operator.
Product Line Growth: Multiple launches—AI Scan Review, Live Design Review, the Dandy Vision intraoral scanner, Dandy Cart, digital dentures, and DSO analytics tools—indicate expanding offerings across hardware, software, and lab services. This cadence suggests increasing breadth from scan capture to manufacturing and practice analytics.
Strategic Partnerships: Sign-ups from practices at more than 80 DSOs and named relationships with multi-location groups are cited alongside frequent presence at major dental meetings. These connections deepen access to scaled customer channels and reinforce commercial momentum.
Our mission is to provide manufacturers and other industrial sectors with insights into the health of machines, processes, and operations to transform how people work and what they can create. A pioneer in Machine Health and Process Health solutions, we use purpose-built AI, trained by industry experts and the world’s largest data library, to help customers eliminate production downtime, improve...
Augury's Top Stability, Growth & Resilience Strengths
Strong Market Position & Advantage: Independent analyst recognition (Verdantix 2025 Green Quadrant) names Augury a Leader, and visible multi‑site deployments with brands like PepsiCo and Colgate indicate scaled adoption. The company is especially noted for machine health and expanded process/production health, marking it among the top tier in a crowded field.
Investor Backing & Capital Strength: A February 2025 Series F raise of $75M at a $1B+ valuation—reported as an up‑round—and potential additional tranches signal sustained investor confidence and runway. Maintaining unicorn status through 2025 alongside expansion metrics underscores access to capital aligned with growth plans.
Product Line Growth: The 2022 acquisition of Seebo extended Augury from machine health into process/production health, while new offerings such as Halo R4000 sensors and ultra‑low‑RPM monitoring broaden asset coverage. Coverage expansion across more machine types supports larger, end‑to‑end production use cases.
SharkNinja is a global product design and technology company, with a diversified portfolio of 5-star rated lifestyle solutions that positively impact people’s lives in homes around the world. Powered by two trusted, global brands, Shark and Ninja, the company has a proven track record of bringing disruptive innovation to market and developing one consumer product after another has allowed SharkNinja...
SharkNinja's Top Stability, Growth & Resilience Strengths
Strong Market Position & Advantage: SEC-cited retail tracking indicates Shark is the #1 floorcare brand in the U.S. by dollar sales and Ninja is the #1 brand in U.S. small kitchen appliances for multiple consecutive years, with Shark also leading in U.K. vacuums. Leadership is reinforced by multi‑billion‑dollar scale and documented category strengths across core U.S./U.K. markets.
Strong Revenue Growth: Recent results show net sales increasing from roughly $5.53 billion in 2024 to about $6.40 billion in 2025, with double‑digit quarterly growth and continued expansion across categories and geographies. Management’s outlook and a new share repurchase authorization further underscore momentum.
Innovation-Driven Growth: Investor materials and profiles describe rapid share gains tied to high‑velocity launches (e.g., Ninja Creami, Shark FlexStyle) and a robust innovation roadmap. Product expansion into new sub‑categories and regions is repeatedly linked to growth durability.
Founded in 2018 by professional makeup artist Gucci Westman. For Westman, there are three vital signs of modern beauty: luxury, efficacy, and clean, consciously-crafted ingredients. For her first makeup line, she combines supremely buttery, rich textures with the best plant-based active ingredients. The ultimate naturally beautiful complexion — now available to everyone. We are creating a new standard in luxury that...
.png)
At Sullivan Steel, we do more than distribute specialty metals; we help fuel innovation in some of the world’s most advanced and demanding industries. Since 1980, we’ve been a trusted partner to aerospace, defense, energy, and other high-performance sectors that rely on precision-engineered steel to perform under pressure. From sourcing ultra-clean steel grades to advising on heat treatment and machining...
Amneal Pharmaceuticals, Inc. (NASDAQ: AMRX) is guided by a simple belief: essential medicines should be accessible to everyone. What began as a promise to deliver high-quality, affordable medicines has evolved into a diversified portfolio spanning complex generics and injectables, biosimilars, and specialty medicines, including more than 290 products, with scale and capabilities that help reach patients across the healthcare system...
Amneal Pharmaceuticals's Top Stability, Growth & Resilience Strengths
Strong Revenue Growth: Recent results show net revenue increased year over year to about $3.02 billion in 2025, with 2026 guidance indicating continued albeit modest expansion. Q4 momentum and management commentary point to ongoing top-line gains supported by launches across segments.
Profitability: The company returned to GAAP profitability in 2025 and expanded adjusted EBITDA, with leverage trending lower after refinancing. Management highlights improving margins and cash generation into 2026.
Diversified Revenue Streams: All three segments—Affordable Medicines, Specialty, and AvKARE—contributed to growth in 2025, while biosimilars and complex products add higher‑value mix alongside branded therapies. Public‑sector initiatives (e.g., CalRx naloxone) and government distribution broaden end‑market exposure.
Leucine is an AI-powered platform that helps pharmaceutical manufacturers in staying compliant and audit-ready while ensuring their medicines reach the patients faster. Using Leucine, Manufacturing, QA, and QC teams can significantly increase productivity and reduce deviations from cGMP guidelines across thousands of complex regulated workflows from material receipt to batch release. Leucine supports manufacturers across all modalities such as small...
Catch is at the forefront of e-commerce. Creating consumer goods, marketing campaigns, and a friendly consumer journey, all in-house.
Ethique is a purpose driven, beauty innovator with a mission to regenerate our planet. We believe business is the catalyst for social and environmental change to benefit people and the planet. Join our revolution and #giveupthebottle. 1 Ethique bar is sold worldwide every 9 seconds. Over 18 million plastic bottles saved so far from being made or disposed of in landfills...
Elementis is a global specialty chemical company, with 1,300 employees operating 17 manufacturing sites across the globe. At Elementis, we bring a distinctive combination of expertise, innovation, and teamwork to every formulation challenge. We create high-value specialty additives that enhance the performance of our customers' products and make a positive change in the world. Combining our leading positions in the science...
Sia Partners is a next generation management consulting firm and pioneer of Consulting 4.0. We offer a unique blend of AI and design capabilities, augmenting traditional consulting to deliver superior value to our clients. Counting 1,800 consultants in 18 countries, we expect to achieve USD 300 million in turnover for the current fiscal year. With a global footprint and expertise...
Integra LifeSciences, a world leader in medical technology with headquarters in Princeton, New Jersey, was founded in 1989 with the acquisition of an engineered collagen technology platform used to repair and regenerate tissue. Since then, Integra has expanded its base regenerative technology product portfolio to include surgical instruments, neurosurgical products and advanced wound care products, through global acquisitions and development...
Cometeer is a hyper-growth, innovation and e-commerce company, revolutionizing the $400+ billion global coffee market. We’ve invented the most technologically advanced brewing system ever built — perfected over years of investment-backed research and development — to deliver quality specialty flash-frozen coffee in a uniquely convenient, meltable, format. No machine is required to create consistently delicious fresh coffee; simply peel back...
Maiden Home is a New York design house that stands on a deep appreciation for good design—design that tells rich stories of originality. Our collections are born of a desire to push the boundaries of form, explore the full potential of exquisite materials, and embrace rare artisanal techniques.
The Vita Coco Company, created in 2004 by Michael Kirban and Ira Liran, produces the leading brand of coconut water in the United States with a growing presence around the world. The Vita Coco Company’s brands include the leading coconut water, Vita Coco; clean energy drink Runa; premium canned water, Ever & Ever; and protein-infused water, PWR LIFT. In 2021, The...
At Mallinckrodt, we use strategic vision and employee-driven momentum to pursue a powerful mission: Listening for needs and delivering solutions. As a leader in specialty pharmaceuticals, we develop, manufacture, market and distribute innovative treatments for underserved patient populations within neurology, rheumatology, hepatology, nephrology, pulmonology, ophthalmology, and oncology; immunotherapy and neonatal respiratory critical care therapies; analgesics; cultured skin substitutes and gastrointestinal...
At Diaceutics we believe that every patient should have access to the right treatment at the right time. We provide the world’s leading pharmaceutical companies with an end-to-end solution for the launch of precision medicine diagnostics enabled by DXRX – The Diagnostic Network®. DXRX is the world’s first diagnostic commercialization platform for precision medicine, integrating multiple pipelines of real-world diagnostic...
Schneider Electric is your energy technology partner. We lead the convergence of electrification, automation, and digital intelligence to make the New Energy Landscape possible. Through platforms like EcoStruxure, we enable buildings, data centers, factories, infrastructure, and grids to operate as open, software-defined systems with intelligence built in at every level. We go beyond connectivity - simplifying complexity and unlocking the...
Schneider Electric's Top Stability, Growth & Resilience Strengths
Strong Revenue Growth: Financial results indicate record revenue and net profit in 2024 with continued organic growth into 2025, supported by strong demand in energy management and data centers. Outlook and backlog point to ongoing momentum.
Strong Market Position & Advantage: Independent accolades and sector rankings consistently place the company at or near the top in energy management, data-center infrastructure, grid digitalization, and supply chain execution. A broad global footprint and brand reputation reinforce a durable competitive position.
Future-Ready Strategy: Strategy emphasizes electrification, digitalization, and AI-driven data centers, backed by sustained R&D and targeted acquisitions like advanced liquid-cooling capabilities. Large-scale investments in U.S. and India operations align capacity with secular demand in data centers, grid modernization, and sustainable solutions.
